Skip to content

Apotheek Loosveldt: what changed

BE 0811.116.671NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€13,810
2024 · €36,554-€22,744
Equity
€192,503
2024 · €187,692+€4,810
Cash
€44,886
2024 · €71,706-€26,820
Balance sheet total
€264,627
2024 · €287,990-€23,362

Largest movements

2024 to 2025
Assets
  • Cash -€26,820

    down €26,820 (-37.4%), from €71,706 to €44,886

    mainly Trade debts (-€9,644) and Stocks and contracts (-€9,561)

  • Tangible fixed assets -€14,486

    down €14,486 (-22.5%), from €64,497 to €50,010

    of which Land and buildings: -€13,936

  • Stocks and contracts +€9,561

    up €9,561 (+9.9%), from €96,536 to €106,097

  • Receivables within one year +€8,201

    up €8,201 (+16.1%), from €50,884 to €59,085

    of which Other amounts receivable: +€8,338

Equity and liabilities
  • Trade debts -€9,644

    down €9,644 (-24.9%), from €38,681 to €29,037

  • Debts after one year -€9,310

    down €9,310 (-28.6%), from €32,586 to €23,276

  • Other debts -€6,287

    down €6,287 (-37.6%), from €16,703 to €10,417

  • Reserves +€4,810

    up €4,810 (+3.4%), from €142,692 to €147,503

  • Tax, wage and social debts -€3,000

    no longer reported in 2025 (was €3,000)

Income statement
  • Gross operating margin -€39,399

    down €39,399 (-50.6%), from €77,918 to €38,519

  • Depreciation -€7,303

    down €7,303 (-33.5%), from €21,789 to €14,486

  • Taxes -€5,958

    down €5,958 (-74.4%), from €8,012 to €2,054

  • Financial charges -€3,902

    down €3,902 (-34.4%), from €11,337 to €7,435

  • Financial income -€1,151

    down €1,151 (-57.6%), from €1,999 to €848

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €36,554
Gross operating margin -€39,399
Depreciation +€7,303
Other operating charges +€645
Financial income -€1,151
Financial charges +€3,902
Taxes +€5,958
Result 2025 €13,810
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€8,499
Investment -€11
Financing -€18,310
Cash 2024 €71,706
Net result for the year +€13,810
Depreciation +€14,486
Stocks and contracts -€9,561
Receivables within one year -€8,201
Deferred charges and accrued income -€170
Trade debts -€9,644
Tax, wage and social debts -€3,000
Other debts -€6,287
Accrued charges and deferred income +€68
Current investments -€11
Debts after one year -€9,310
Contributions, distributions and other -€9,000
Cash 2025 €44,886
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €287,990 €264,627 -€23,362 -8.1%
Fixed assets 21/28 €64,497 €50,010 -€14,486 -22.5%
Tangible fixed assets 22/27 €64,497 €50,010 -€14,486 -22.5%
Land and buildings 22 €63,833 €49,897 -€13,936 -21.8%
Plant, machinery and equipment 23 €663 €113 -€550 -83.0%
Current assets 29/58 €223,493 €214,617 -€8,876 -4.0%
Stocks and contracts in progress 3 €96,536 €106,097 +€9,561 +9.9%
Stocks 30/36 €96,536 €106,097 +€9,561 +9.9%
Amounts receivable within one year 40/41 €50,884 €59,085 +€8,201 +16.1%
Trade receivables 40 €44,122 €43,985 -€137 -0.3%
Other amounts receivable 41 €6,762 €15,100 +€8,338 +123%
Current investments 50/53 €3,527 €3,539 +€11 +0.3%
Cash at bank and in hand 54/58 €71,706 €44,886 -€26,820 -37.4%
Deferred charges and accrued income 490/1 €840 €1,010 +€170 +20.3%
Total equity and liabilities 10/49 €287,990 €264,627 -€23,362 -8.1%
Equity 10/15 €187,692 €192,503 +€4,810 +2.6%
Contributions 10/11 €45,000 €45,000 = 0.0%
Reserves 13 €142,692 €147,503 +€4,810 +3.4%
Distributable reserves 133 €142,692 €147,503 +€4,810 +3.4%
Amounts payable 17/49 €100,297 €72,125 -€28,173 -28.1%
Amounts payable after more than one year 17 €32,586 €23,276 -€9,310 -28.6%
Financial debts 170/4 €32,586 €23,276 -€9,310 -28.6%
Amounts payable within one year 42/48 €67,694 €48,763 -€18,930 -28.0%
Current portion of amounts payable after more than one year 42 €9,310 €9,310 = 0.0%
Trade debts 44 €38,681 €29,037 -€9,644 -24.9%
Suppliers 440/4 €38,681 €29,037 -€9,644 -24.9%
Taxes, remuneration and social security 45 €3,000 - -€3,000
Taxes 450/3 €3,000 - -€3,000
Other amounts payable 47/48 €16,703 €10,417 -€6,287 -37.6%
Accrued charges and deferred income 492/3 €18 €86 +€68 +380%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €21,789 €14,486 -€7,303 -33.5%
Other operating charges 640/8 €2,226 €1,581 -€645 -29.0%
Gross operating margin 9900 €77,918 €38,519 -€39,399 -50.6%
Operating profit (loss) 9901 €53,903 €22,451 -€31,452 -58.3%
Financial income 75/76B €1,999 €848 -€1,151 -57.6%
Recurring financial income 75 €1,999 €848 -€1,151 -57.6%
Financial charges 65/66B €11,337 €7,435 -€3,902 -34.4%
Recurring financial charges 65 €11,337 €7,435 -€3,902 -34.4%
Profit (loss) for the period before taxes 9903 €44,566 €15,864 -€28,702 -64.4%
Income taxes 67/77 €8,012 €2,054 -€5,958 -74.4%
Profit (loss) for the period 9904 €36,554 €13,810 -€22,744 -62.2%
Profit (loss) for the period to be appropriated 9905 €36,554 €13,810 -€22,744 -62.2%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€170,487 to €200,181

Midpoint €182,860 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €192,503
Capitalised earnings €148,471 to €207,860
Indication €170,487 to €200,181

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€192,503
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€192,503

Capitalised earnings

net result for the year (9904)
2025
€13,810
2024
€36,554
2023
€11,993
2022
€26,359
2021
€3,179
Average result
€20,786
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€148,471 / €173,217 / €207,860

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.